ZukoBid.
Try it free
Federal contractor profile

Seqirus INC.

Holly Springs, NC · Not a small business · Part of Seqirus INC
UEI Z6N1LJ2RD6E3 · CAGE 7L0Y8
Contracts won
8
since Feb 2024 · last Sep 2026
Total value
$430M
including options
Buying offices
1
government offices it sold to
Usual competition
—

Wins by fiscal year

FY2024
4 · $358M
FY2026
4 · $72M

Who it sells to

Barda - Aspr / Daappo / Barda Dcma
Administration For Strategic Preparedness And Response · 8 wins · $430M

What it wins

Drugs And Biologicals
PSC 6505 · 7 wins · $430M
Health R&D Services; Health Care Services; Applied Research
PSC AN12 · 1 win · $565K

Ending in the next 12 months

Contracts that end soon are usually re-bid. These could be openings for a competitor.
The Purpose Of This Requirement Is To Provide Medical Countermeasures (Mcms), Such As Vaccines And Adjuvants, For Pandemic Preparedness And Response Or As Required In Response To A Hhs Designated
Barda - Aspr / Daappo / Barda Dcma · ends May 2027 · $8.1M
Two-Way Immunogenicity Testing On Existing Clinical Trial Sera To Confirm Immunogenicity Superiority Of A New Vaccine Strain Versus The Prototype Strain
Barda - Aspr / Daappo / Barda Dcma · ends Nov 2026 · $450K
The Purpose Of This Requirement Is To Provide Medical Countermeasures (Mcms), Such As Vaccines And Adjuvants, For Pandemic Preparedness And Response Or As Required In Response To A Hhs Designated
Barda - Aspr / Daappo / Barda Dcma · ends May 2027 · $396K

Recent awards

DateWhatOfficeValueOffers
Sep 2026Formulation And Filling Of Mf59-Adjuvanted Cell-Based A/Henan/4-10cnic/2022 (H3n8)-Like Vaccine And Clinical Trial ImplementationBarda - Aspr / Daappo / Barda Dcma$43M—
Sep 2026Manufacture And Stability Studies Of Thimerosal-Free Pandemic Influenza Vaccine Multidose Vials (Mdvs)Barda - Aspr / Daappo / Barda Dcma$29M—
May 2026Extractable/ Leachable & Stability Study To Support Long-Term Bulk Storage In Single-Use ContainersBarda - Aspr / Daappo / Barda Dcma$565K—
Apr 2026Two-Way Immunogenicity Testing On Existing Clinical Trial Sera To Confirm Immunogenicity Superiority Of A New Vaccine Strain Versus The Prototype StrainBarda - Aspr / Daappo / Barda Dcma$450K—
Sep 2024The Purpose Of This Task Order Is To Perform A Short-Term Physical And Chemical Compatibility (Pc) Study On The Antigen And Mf59 Dosing Combinations To Support Of The Intended Hold Time For The Barda Sponsored Bpi-23-001 Study.Barda - Aspr / Daappo / Barda Dcma$24K—
May 2024This Task Order Establishes Services For H5 Pandemic Readiness For Acquisition Of Medical Countermeasures (Mcms) For Pandemic Influenza And Emerging Diseases Preparedness And Response, Under Idiq 75a50122d00004.Barda - Aspr / Daappo / Barda Dcma$349M—
Feb 2024The Purpose Of This Requirement Is To Provide Medical Countermeasures (Mcms), Such As Vaccines And Adjuvants, For Pandemic Preparedness And Response Or As Required In Response To A Hhs DesignatedBarda - Aspr / Daappo / Barda Dcma$8.1M—
Feb 2024The Purpose Of This Requirement Is To Provide Medical Countermeasures (Mcms), Such As Vaccines And Adjuvants, For Pandemic Preparedness And Response Or As Required In Response To A Hhs DesignatedBarda - Aspr / Daappo / Barda Dcma$396K—
Is this your company?

Claim this profile free, and see the open contracts that fit what you win: who else bids, what the government paid last time, and what to bid.

Claim this profile freeCompete with Seqirus INC. →
From federal contract award records (SAM.gov), base awards over $10K since fiscal year 2024, updated daily. Values include options where reported.
ZukoBid is an independent service, not affiliated with or endorsed by any government agency. Figures come from public records and may contain errors; always check the official listing before you bid. Spotted an error about Seqirus INC.? Request a correction.